NCT03420963 2026-03-03
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
Clinical Trials
9 trialsNCT04616248 2026-01-07
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
Phase 1 Active not recruiting
NCT02811523 2025-11-26
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
University Health Network, Toronto
Phase 1 Recruiting
NCT03093909 2025-11-10
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT01803152 2024-07-03
Dendritic Cell Vaccine for Children and Adults With Sarcoma
University of Miami
Phase 1 Completed
NCT03462316 2023-04-12
NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma
Sun Yat-sen University
Phase 1 Unknown
NCT02303366 2017-10-18
BOSTON II
Peter MacCallum Cancer Centre, Australia
Phase 1 Completed
NCT01491594 2014-04-02
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
Duke University
Phase 1 Terminated
NCT00168129 2011-12-09
Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases
AHS Cancer Control Alberta
Phase 1 Completed